Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Closed / expired for Atlas action — Grady's current published due date of September 15, 2026 has passedAtlas Opportunity Score 92/100
GA-GRADY-RFP26003TMGeorgiaGrady Health SystemHealthcare Technology VendorHealthcare Procurement & Contracts

Georgia Grady Health System Enterprise Patient Monitoring Solutions — RFP #26003TM

Grady Health System's current supplier page lists RFP #26003TM Enterprise Patient Monitoring Solutions as due September 15, 2026, and the RFP cover states September 15 at 2:00 PM. The same RFP also repeats September 11, 2026 at 2:00 PM in its schedule, response instructions, and Appendix C, and the published materials do not state a time zone. Atlas treats the controlling deadline as unresolved pending direct written confirmation from Grady.

FundingNo guaranteed contract value or award ceiling is publicly stated. Respondents must provide comprehensive pricing for the enterprise solution, including applicable equipment, software, implementation, training, support and lifecycle costs.
DeadlineGrady's current supplier page lists RFP26003TM Enterprise Patient Monitoring as due September 15, 2026. The base RFP previously contained conflicting September 11 and September 15 response dates and did not publish a time zone. Regardless of that internal conflict, the latest date currently published by Grady has now passed.
Last verifiedSeptember 17, 2026
Required next actionDo not initiate outreach, partner pursuit, or direct submission for RFP26003TM. Preserve the record for intelligence and future enterprise-monitoring opportunities. Reopen only if Grady posts an official extension, amendment, reissue, or successor solicitation with a future controlling deadline.

Broad Eligibility

Qualified enterprise patient-monitoring manufacturers, authorized distributors, resellers or implementation partners able to provide a comprehensive, fully integrated enterprise-wide monitoring solution and satisfy Grady’s experience, reference, interoperability, implementation, cybersecurity, training, maintenance and lifecycle requirements.

Atlas Analysis

Major enterprise healthcare technology procurement. Grady's final vendor Q&A provides concrete deployment scale: 906 monitored beds, 127 telemetry boxes, 140 central stations, and 451 Med-Surg bedside vital-sign monitors used for spot-check temperature, SpO2, and non-invasive blood pressure; the Q&A says existing Zoll transport monitors should not be part of this RFP. This creates a real but limited N9+ overlap around spot-check vital-sign workflows. The mandatory procurement is still an enterprise monitoring platform requiring continuous high-acuity monitoring, telemetry, central stations, Epic integration, cybersecurity, implementation, maintenance, lifecycle support, and demonstrated comparable experience. The controlling submission deadline remains unresolved in Grady's own current materials: the supplier page and cover point to September 15, while Section 3, response instructions, and Appendix C point to September 11, and no time zone is published. Atlas Opportunity Score 92/100. N9+ Direct Vendor Fit 52/100, conditional Path C only. Not a TRUE Path A opportunity for Dr. Miltie.

Opportunity Overview

Active now. Grady Health System is soliciting RFP #26003TM, Enterprise Patient Monitoring Solutions, for a comprehensive, fully integrated enterprise patient-monitoring platform. Grady’s live supplier portal lists the opportunity as due September 15, 2026, and the RFP cover states 2:00 PM. The same base RFP also contains conflicting September 11, 2026 at 2:00 PM response language in Section 3, the response instructions, and Appendix C. Grady’s current supplier page lists September 15, 2026, while the RFP cover states September 15, 2026 at 2:00 PM, but the published materials do not state a time zone. Atlas therefore treats the controlling deadline as unresolved and requires direct written confirmation from Grady before relying on September 15 for a new submission.

Scope and Scale

The RFP requires an enterprise-wide solution spanning high-acuity, intermediate, procedural, emergency, transport and ambulatory environments, with hardware, software, licensing, interfaces, implementation, training, maintenance and long-term support. Required capabilities include continuous monitoring, central monitoring, alarm management, cybersecurity, scalability and interoperability with Grady’s clinical and technical infrastructure, including Epic.

Grady’s published vendor Q&A identifies approximately 906 monitored beds, 127 telemetry boxes, 140 central stations and 451 Med-Surg bedside vital-sign monitors for spot checks including temperature, SpO2 and non-invasive blood pressure. Grady also states that vendors are being asked to quote net-new monitors. Existing centralized monitoring, virtual surveillance and remote telemetry workflows are already present, and Grady considers remote access to live monitoring information desirable.

Who Should Evaluate This RFP

The strongest respondents are manufacturers, authorized distributors, resellers or implementation partners that can satisfy the full enterprise requirements, demonstrate comparable large-health-system implementations, provide at least three relevant client references, integrate with Epic and other clinical systems, meet cybersecurity requirements, and support implementation and lifecycle management. Grady’s supplier page states that businesses selected to provide goods, equipment or services must be registered through its Vendormate vendor credentialing process.

Atlas Analysis

Atlas Opportunity Score: 92/100. This is a major active healthcare technology procurement with a large enterprise deployment footprint and substantial monitoring, interoperability and virtual-workflow requirements.

N9+ Direct Vendor Fit: 52/100, conditional Path C. The N9+ overlaps with a subset of the procurement—particularly spot-check vital signs, connected assessment and remote-care workflows—but the verified RFP requires a comprehensive enterprise platform capable of continuous high-acuity monitoring, telemetry, central stations, advanced parameters, cybersecurity, Epic interoperability and lifecycle support. Dr. Miltie should therefore not treat this as a standalone Path A bid. A lawful role would be conditional on a qualified enterprise prime confirming that the N9+ can be integrated as an allowable component or peripheral within its compliant full-scope solution.

QC Healthcare Fit: 10/100. The solicitation is principally for monitoring technology and implementation rather than physician coverage or clinical staffing.

Next Action

Qualified enterprise-monitoring vendors should review the live Grady supplier page, the full RFP, the posted vendor Q&A and all current attachments, resolve the official deadline conflict directly with Grady before relying on the September 15 date, confirm the controlling submission time and time zone in writing, and confirm complete technical and cybersecurity compliance before attempting a response. Atlas should only pursue an N9+ role through a qualified prime or integration partner if the prime confirms that the device is both technically compatible and allowable within the complete enterprise solution.

Official sources: Grady Health System Supplier Portal; RFP #26003TM; and Vendor Q&A Responses.

Source verificationReferenced source · www.gradyhealth.orgAtlas last verified this record September 17, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗